ASP Isotopes (NASDAQ:ASPI) Receives New Coverage from Analysts at Canaccord Genuity Group

Canaccord Genuity Group assumed coverage on shares of ASP Isotopes (NASDAQ:ASPI) in a research note published on Friday, Marketbeat Ratings reports. The firm issued a buy rating and a $4.50 price objective on the stock.

Separately, HC Wainwright decreased their price target on ASP Isotopes from $5.50 to $4.50 and set a buy rating on the stock in a research note on Wednesday, August 7th.

ASP Isotopes Stock Up 3.0 %

Shares of ASP Isotopes stock opened at $3.10 on Friday. The company has a debt-to-equity ratio of 2.06, a current ratio of 4.00 and a quick ratio of 4.00. The company has a market capitalization of $160.47 million, a P/E ratio of -5.85 and a beta of 5.11. ASP Isotopes has a 1 year low of $0.84 and a 1 year high of $5.67. The business has a 50-day moving average of $2.48 and a two-hundred day moving average of $3.31.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings results on Monday, August 19th. The company reported ($0.24) earnings per share for the quarter. The company had revenue of $1.02 million during the quarter. As a group, equities analysts predict that ASP Isotopes will post -0.24 EPS for the current year.

Insider Activity at ASP Isotopes

In other news, major shareholder Ak Jensen Investment Managemen bought 61,849 shares of the firm’s stock in a transaction that occurred on Wednesday, July 10th. The stock was acquired at an average cost of $3.40 per share, with a total value of $210,286.60. Following the transaction, the insider now directly owns 6,678,723 shares of the company’s stock, valued at approximately $22,707,658.20. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 26.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On ASP Isotopes

A number of hedge funds have recently modified their holdings of ASPI. Vanguard Group Inc. grew its position in shares of ASP Isotopes by 479.1% in the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after purchasing an additional 844,705 shares in the last quarter. Marshall Wace LLP boosted its holdings in ASP Isotopes by 389.6% in the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after purchasing an additional 433,734 shares during the period. Rathbones Group PLC grew its position in shares of ASP Isotopes by 27.5% during the 2nd quarter. Rathbones Group PLC now owns 195,915 shares of the company’s stock valued at $600,000 after purchasing an additional 42,243 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of ASP Isotopes by 5.7% in the second quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock worth $526,000 after purchasing an additional 9,200 shares during the period. Finally, Bank of New York Mellon Corp bought a new position in ASP Isotopes in the 2nd quarter worth about $381,000. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.